Despite innovative new research, many cell and gene therapies do not make it all the way to the patients. Researchers and ...

NINGBO, ZHEJIANG, CHINA, February 3, 2026 /EINPresswire.com/ -- Ningbo Qinmeng Maternal and Child Products Co., Ltd., a ...

Let's check out two exciting biotech stocks that may climb 58% and 200%, according to Wall Street.

The search space for protein engineering grows exponentially with complexity. A protein of just 100 amino acids has 20100 ...

The convergence of CNS and oncology research amplifies the significance of Oncotelic’s recent intellectual property updates for OT-101. Developed in collaboration with Sapu Bioscience, the expanded ...

CRISPR Therapeutics' CASGEVY gene-editing therapy targets severe SCD and TDT. Click here to read why CRSP stock is rated as a Buy.

Amgen’s bad luck in lupus may finally be coming to an end. Daxdilimab, a monoclonal antibody acquired from Horizon Therapeutics in 2023, hit the primary endpoint in a phase 2 trial for discoid lupus ...

Providing cutting-edge biolab coworking, equipment access, and startup support to bio innovators and early-stage ventures from Alameda to the world. BADASS Labs empowers innovators to focus on ...

New Record Financial Results: Total revenues of $30.1 million, gross profit before fair value adjustments of $13.5 million or 45% and Adjusted EBITDA of $8.8 million 1, supported by operating cash ...

Fueled by advances in biomarkers, brain mapping, and AI, investment in neuro and CNS innovation shows no signs of slowing, even amid costly setbacks. BioSpace spoke to investors at JPM26 to get their ...

Massachusetts-based Moderna Inc. (NASDAQ: MRNA) is seeing fresh momentum in recent weeks, with the stock off to a flying start in 2026. The company that rose to prominence during the COVID-19 pandemic ...

SOMERSET, N.J., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today provided an update on the Company's recent ...